Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Warning letter cites hormone creams

This article was originally published in The Tan Sheet

Executive Summary

Louisville, Ky.-based Cosmed Labs receives a warning letter from FDA saying online information and labeling position four products as hormone-containing drugs. The products - AIM Renewed Balance Body Cream, Products of Nature Natural Woman Progesterone Cream, Products of Nature Relevamine GS and Dr. Janet's Glucosamine Cream - are listed in the Aug. 3 letter. FDA also points out a number of the "objectionable" claims, including one for the glucosamine cream stating "the ingredients in this formula work to soothe joints." The agency says the products are unapproved drugs because all topically applied hormone products, except those containing hydrocortisone, are considered new drugs. Further, three of the formulas are misbranded because the adequacy of their indications has not been established, and all four are adulterated because production methods do not conform to drug good manufacturing practices

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104417

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel